TY - JOUR
T1 - Structural and functional insights into the biofilm-associated bcef tyrosine kinase domain from burkholderia cepacia
AU - Mayer, Michal
AU - Matiuhin, Yulia
AU - Nawatha, Mickal
AU - Tabachnikov, Orly
AU - Fish, Inbar
AU - Schutz, Nili
AU - Dvir, Hay
AU - Landau, Meytal
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8/12
Y1 - 2021/8/12
N2 - BceF is a bacterial tyrosine kinase (BY-kinase) from Burkholderia cepacia, a Gram-negative bacterium accountable for respiratory infections in immunocompromised and cystic fibrosis patients. BceF is involved in the production of exopolysaccharides secreted to the biofilm matrix and promotes resistant and aggressive infections. BY-kinases share no homology with mammalian kinases, and thereby offer a means to develop novel and specific antivirulence drugs. Here, we report the crystal structure of the BceF kinase domain at 1.85 Å resolution. The isolated BceF kinase domain is assembled as a dimer in solution and crystallized as a dimer in the asymmetric unit with endogenous adenosine-diphosphate bound at the active sites. The low enzymatic efficiency measured in solution may be explained by the partial obstruction of the active sites at the crystallographic dimer interface. This study provides insights into self-assembly and the specific activity of isolated catalytic domains. Several unique variations around the active site compared to other BY-kinases may allow for structure-based design of specific inhibitors to target Burkholderia cepacia virulence.
AB - BceF is a bacterial tyrosine kinase (BY-kinase) from Burkholderia cepacia, a Gram-negative bacterium accountable for respiratory infections in immunocompromised and cystic fibrosis patients. BceF is involved in the production of exopolysaccharides secreted to the biofilm matrix and promotes resistant and aggressive infections. BY-kinases share no homology with mammalian kinases, and thereby offer a means to develop novel and specific antivirulence drugs. Here, we report the crystal structure of the BceF kinase domain at 1.85 Å resolution. The isolated BceF kinase domain is assembled as a dimer in solution and crystallized as a dimer in the asymmetric unit with endogenous adenosine-diphosphate bound at the active sites. The low enzymatic efficiency measured in solution may be explained by the partial obstruction of the active sites at the crystallographic dimer interface. This study provides insights into self-assembly and the specific activity of isolated catalytic domains. Several unique variations around the active site compared to other BY-kinases may allow for structure-based design of specific inhibitors to target Burkholderia cepacia virulence.
KW - Bacterial Proteins/chemistry
KW - Biofilms/growth & development
KW - Burkholderia cepacia/physiology
KW - Crystallography, X-Ray/methods
KW - Humans
KW - Protein Structure, Secondary
KW - Protein Structure, Tertiary
KW - Protein-Tyrosine Kinases/chemistry
KW - Virulence/physiology
UR - http://www.scopus.com/inward/record.url?scp=85112184390&partnerID=8YFLogxK
U2 - 10.3390/biom11081196
DO - 10.3390/biom11081196
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34439861
AN - SCOPUS:85112184390
VL - 11
JO - Biomolecules
JF - Biomolecules
IS - 8
M1 - 1196
ER -